Supporting SMEs with Global Healthcare
Development, Regulatory
and Commercialisation
Regulatory Affairs Australia | Adjutor is a leading regulatory affairs consulting company operating in the Asia-Pacific region. We assist pharmaceutical, biotech, medical device and other life science companies to register their products and access the diverse and rapidly growing global markets.
Specialists in working with SMEs for end-to-end development, regulatory and commercialisation of medicines and medical devices. Get the Adjutor Advantage today.Contact us
WHY CHOOSE US
Quality and Training | Adjutor will provide the skills you need to make sure your quality system is both appropriate for your business and also compliant.
1
Our Responsiveness
Quick to respond with an appreciation of your commercial drivers.
Learn more about us
Strategy and Project Management | Key to everything we do at Adjutor.We want to help you design a focused vision of where you want to go with development and commercialisation and then to help you achieve that vision through good planning.
Corporate Flexibility | Flexibility gives Adjutor the capacity to understand and adjust to your evolving needs, quickly and calmly, so that we can deal with unexpected problems or tasks effectively.
Experience and Expertise | The Adjutor management team has been involved in the successful global development and commercialization of prescription medicines and devices for over 30 years.
Sponsorship and Commercialisation | Adjutor can provide experienced local country sponsors to help you make parallel regulatory submissions to gain either simultaneous or staggered approvals.
Regulatory Affairs and Market Access | At Adjutor, we are specialists in drug development and are able to facilitate and contribute to activities from lab to dossier.
OUR SERVICES
How we can help
No matter what your stage of product development or lifecycle, we can provide an experienced, tailored team to support your business objectives.
Strategy and Project Management
Strategy and Project Management | Key to everything we do at Adjutor.We want to help you design a focused vision of where you want to go with development and commercialisation and then to help you achieve that vision through good planning.
Sponsorship and Commercialisation
Sponsorship and Commercialisation | Adjutor can provide experienced local country sponsors to help you make parallel regulatory submissions to gain either simultaneous or staggered approvals.
Development and Clinical
Development and Clinical | With a deep understanding of regulatory requirements, we can help you meet international standards by designing studies and managing contracted providers
Regulatory Affairs 
and Market Access
Regulatory Affairs and Market Access | At Adjutor, we are specialists in drug development and are able to facilitate and contribute to activities from lab to dossier.
Quality and Training
Quality and Training | Adjutor will provide the skills you need to make sure your quality system is both appropriate for your business and also compliant.
Browse our services
Learn more about us
BrowseInsights
See all articles
Medical device registration in Australia is a complex but crucial process that ensures the safety and performance of devices entering the healthcare market.
Medical Device Registration in Australia
Blog Posts19 Jul 2024
Registering a medical device in Australia is a complex but crucial process that ensures the safety and performance of devices entering the healthcare market. Navigating the regulatory landscape of the Therapeutic...
How to register a medicine in Australia: There are a number of pathways to medicine registration in Australia, some of which enable the fast tracking of product onto the Australian market.
How to Register a Medicine in Australia
Blog Posts28 Jun 2024
Navigating the complexities of product development, clinical development, regulatory services for product registration/ lifecycle management, quality/QMS, training and commercialisation requires a tailored approach that balances local requirements and global...
Concept of teamwork: Close-Up of hands business team showing unity with putting their hands together.
The Adjutor Healthcare Group and Axis Health Co Announce a Strategic Partnership to Drive Client Success
News Releases19 Jun 2024
...
Enter the Dragon: Navigating Hong Kong’s Medicines Regulatory System in 2024
Blog Posts08 Feb 2024
The Year of the Dragon stands as a fitting emblem for Hong Kong’s medicines regulatory system, symbolising strength, resilience, and vigilant...
The Adjutor Healthcare Group Expands Global Presence with the Establishment of Adjutor Healthcare Hong Kong
News Releases08 Feb 2024
Today marks a significant milestone for the Adjutor Healthcare Group, as we proudly announce the establishment of Adjutor Healthcare Hong Kong, further solidifying our commitment to excellence supporting global healthcare, development,...
Personalised Medical Devices, along with four new sub-categories, now replace the former Custom-made Medical Devices regulation.
Custom-made Medical Devices in Australia: Now it’s Personal(ised)
Blog Posts05 Mar 2021
Recent changes in TGA Medical Device Regulations In December 2020, TGA released a new Personalised Medical Device Guideline along with a suite of new names and definitions that have shaken up...
Artificial Intelligence Regulation. AI poses ethical, legal, and socio-economic dilemmas such as data sensitivity, privacy, and cyber security.
Is Artificial Intelligence Becoming Too Smart for Regulators?
Blog Posts28 Jan 2021
Is Artificial Intelligence Becoming Too Smart for Regulators? AI is Everywhere and it isn’t that New! The term ‘artificial intelligence’ (AI) was first coined in the 1950s. Since then, this disruptive...
Despite the postponement of the EU Medical Devices Regulation implementation to May 2021 appearing to offer breathing room, it has actually shortened the transition time for many manufacturers!
EU MDR: Are ROW Device Sponsors Ready for the Ripple Effect?
Blog Posts26 Nov 2020
The long-awaited transition to the EU Medical Devices Regulation (MDR) is looming. The regulatory realm of medical devices is in a state of flux and poised on the brink of the...
2020 budget cash splash on high tech and science recovery. Australian science and technology sectors are talking about a ‘research revival’ as the Federal Government splashes the cash in the 2020 Budget.
Australian Government Cash Splash on High Tech Recovery
Blog Posts15 Oct 2020
Australian science and technology sectors are talking about a ‘research revival’ as the Federal Government splashes the cash in the 2020 Budget. 2020 Budget Cash Splash Thanks to COVID-19, early October...
TGA's new Product Information (PI) Form: If you need support to meet the 31 December 2020 deadline, we’re here to help.
The Pointy End of the TGA (PI) Reformatting Transition Period
Blog Posts20 Mar 2020
By now, we should all be very familiar with the new Form for providing Product Information (PI) for Australia. Each time you make a change to a PI, be it safety-related...

Ready for growth?

Contact us today and let's work together to achieve your goals. Whether you have a question, need more information, or want to discuss your project, our team is here to help.Let's talk
This is the official Adjutor Healthcare Icon. It is subject to copyright and may not be used in any way or form without the express permission of Adjutor Healthcare Pty Ltd.Adjutor Healthcare Pty Ltd is part of a worldwide network that spans right across the globe. We provide seamless services across development and commercialisation of your products internationally.
Privacy PolicyDesign by Blueboat